A European Union-based double-blind study, placebo-controlled Phase 2 clinical trial involving ivermectin in 100 patients with mild COVID-19 recently produced results for the world. Based…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.